With recent advances in chemotherapy for unresectable pancreatic ductal adenocarcinoma (PDAC) with liver metastasis (LM), attempts have been made to resect the primary tumor in patients showing favorable responses to anti-cancer treatment (so-called “conversion surgery”; CS). This study aimed to clarify the outcomes of CS for PDAC with LM in a nationwide multicenter study. This retrospective, multicenter study was conducted as a project study of the Japan Pancreas Society and included patients with PDAC with LM at initial diagnosis, diagnosed radiologically or intraoperatively (occult LM), who underwent CS after at least 4 months of chemotherapy between 2010 and 2022. Survival outcomes and prognostic factors were analyzed. 90 patients were enrolled from 31 Japanese institutions. Median duration of preoperative chemotherapy was 10.4 (range, 4.2–58.5) months, and gemcitabine plus nab-paclitaxel was the most common first-line regimen, followed by folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin. Liver metastasectomy was performed in 27 patients (30
OBJECTIVE:While drug-eluting treatment is a first-line therapy for femoropopliteal (FP) lesions, long-term comparative data between drug-eluting stents (DES) and drug-coated balloons (DCB) in real-world practice are scarce. We aimed to compare the 3-year outcomes of DES versus DCB for symptomatic FP disease. METHODS:We conducted a retrospective analysis of the CILANTRO study, a multicenter registry combining data from the CAPSICUM, POPCORN, and POPCORN Type R studies. Patients treated with either DES or DCB for symptomatic FP lesions were included. To minimize selection bias, we performed 1:1 propensity score matching. The primary outcome was clinically driven target lesion revascularization (TLR), while secondary outcomes included restenosis. RESULTS:A total of 2651 patients treated with DCB and 972 with DES were identified. Propensity score matching extracted 912 pairs with well-balanced baseline characteristics. The median follow-up period was 31.6 months. The 3-year rate of TLR was not significantly different between the DCB and DES groups (23.3% vs. 18.8%; hazard ratio, 1.19 [95% confidence interval, 0.93-1.53]; p = 0.16). Interaction analysis revealed that a more marked increased risk of TLR in the DCB group in patients with semi-compliant balloon use or without non-compliant balloon use (p = 0.017 and 0.018). The 3-year rate of restenosis was significantly higher in the DCB group than in the DES group (38.1% vs. 26.3%; hazard ratio, 1.77 [1.43-2.19]; p < 0.001). CONCLUSIONS:In this propensity score-matched analysis, the 3-year rate of TLR was not significantly different between DCB and DES, although DES demonstrated lower restenosis rate. Nevertheless, DCB remains a clinically viable option, and our sub-analysis suggests that balloon selection for pre-dilatation may influence its efficacy.
The sonographic glandular tissue component (GTC) is a potential imaging biomarker for stratifying breast cancer risk in women with dense breasts. This study evaluated the reproducibility, reliability, and clinical applicability of GTC classification and GTC-based sonographic breast density assessment in a multicenter observer study. Fifteen readers (nine physicians and six sonographers) from 12 institutions independently assessed 100 paired ultrasound images twice, 1 month apart, with the dataset rearranged for the second reading. GTC was qualitatively classified into four categories according to its estimated proportion within the fibroglandular tissue (FGT): minimal, mild, moderate, and marked; minimal/mild were grouped as low GTC and moderate/marked as high GTC. Sonographic breast density was categorized as sonographic dense breast (high GTC), sonographic non-dense breast (visible fat lobules), or intermediate, with intermediate cases further divided into high or low categories using an FGT-to-FAT (subcutaneous and retromammary fat) ratio cutoff of 1. Interobserver and intraobserver agreement was evaluated using κ statistics. Substantial interobserver agreement was observed for the four-class GTC classification, the two-class GTC classification, and sonographic breast density assessment. Intraobserver agreement was moderate for the four-class GTC classification and substantial for the two-class GTC classification and sonographic breast density assessment. The majority-vote sonographic breast density assessment showed substantial agreement with the mammographic ground truth, whereas individual-reader assessments showed moderate concordance with mammographic breast density both overall and in intermediate-density breasts. No significant differences in agreement were observed between physicians and sonographers. Substantial interobserver agreement and moderate-to-substantial intraobserver agreement support the reproducibility and reliability of GTC classification and GTC-based sonographic breast density assessment.
INTRODUCTION:Situs inversus totalis (SIT) is a rare congenital anomaly characterized by complete mirror-image transposition of thoracic and abdominal organs. Although laparoscopic colectomy in SIT has been increasingly reported, the reversed anatomy and inherent limitations of laparoscopy make such procedures technically demanding. Robotic-assisted surgery may overcome these issues by providing enhanced ergonomics and intuitive instrument control, yet reports in SIT remain scarce. CASE PRESENTATION:A 51-year-old man with SIT presented with anal bleeding and was diagnosed with sigmoid colon cancer. Preoperative CT confirmed complete visceral inversion without distant metastasis. Robotic-assisted sigmoidectomy with D3 lymphadenectomy was performed using the da Vinci Xi surgical system. A patient-specific port configuration was designed based on preoperative imaging, minimized arm collisions, and optimized instrument mobility. The procedure was uneventful, with an operative time of 232 minutes and minimal blood loss. The patient was discharged on POD 7 without complications. Histopathological examination revealed pT3, pN1a, cM0, Stage IIIB adenocarcinoma. CONCLUSIONS:This case demonstrates that robotic-assisted colectomy can effectively overcome the ergonomic and technical challenges posed by SIT. Patient-specific port mapping, guided by preoperative imaging, is essential to maximize the benefits of robotic technology. Furthermore, this report contributes to the limited evidence supporting robotic colectomy as a feasible and advantageous approach for patients with SIT.